Vasomotor symptoms decrease in women with breast cancer randomized to treatment with applied relaxation or electro-acupuncture: a preliminary study

References

• Stenbeck M. Breast. Acta Oncol 1995;34\(Suppl 4):49–51
   Google Scholar
• Key TJ, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988;24:29–43
   PubMedGoogle Scholar
• Persson I, Bergstrom R, Barlow L, Adami H-0. Recent trends in breast cancer incidence in Sweden. Br J Cancer 1998;77:167–9
   PubMed Web of Science ®Google Scholar
• Million Women Study collaboration. Breast cancer and hormone replacement therapy in the Million Women Study. Lancet 2003;362:419–27
   PubMed Web of Science ®Google Scholar
• Love RR, Cameron L, Connell B, Levanthal H. Symptoms associated with tamoxifene treatment in postmenopausal women. Arch Intern Med 1991;151:1842–7
   PubMed Web of Science ®Google Scholar
• Coup R, Helzlouer K, Fetting J. Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 1995;13:2737–44
   Google Scholar
• Seifert M, Galid A, Kubista E. Estrogen replace-ment therapy in women with a history of breast cancer. Maturitas 1999;32:63–8
   Google Scholar
• Holmberg L, Andersson H. HABITS (hormonal replacement therapy after breast cancer — is it safe? A randomised comparison: trial stopped. Lancet 2004;363:453–5
   PubMed Web of Science ®Google Scholar
• Freedman RR, Woodward S. Behavioural treat-ment of menopausal hot flushes: evaluation by ambulatory monitoring. Am J Obstet Gynecol 1992;167:436–9
   PubMed Web of Science ®Google Scholar
• Hunter M, Liao KLM. Evaluation of a four session cognitive-behavioural intervention for menopausal hot flushes. Br J Health Psychol 1996;1:113–25
   Web of Science ®Google Scholar
• Wyon Y, Lindgren R, Lundeberg T, Hammar M. Effects of acupuncture on climacteric vasomotor symptoms, quality of life and urinary excretion of neuropeptides among postmenopausal wo-men. Menopause 1995;2:3–12
   Web of Science ®Google Scholar
• Loprinzi C, Kugler J, Sloan J, et al. Venlaxafine in management of hot flashes in survivors of breast cancer: a randomized controlled trial. Lancet 2000;365:2059–63
   Web of Science ®Google Scholar
• Wijma K, Melin A, Nedstrand E, Hammar M. Treatment of menopausal symptoms with ap-plied relaxation: a pilot study. J Behav Ther Exp Psychiatry 1997;28:251–64
   PubMed Web of Science ®Google Scholar
• Freedman RR, Woodward S, Sabharwal SC. a-2 adrenergic mechanism in menopausal hot flushes. Obstet Gynecol 1990;76: 573–8
   Google Scholar
• Spencer RL, Hruby VJ, Burks TF. Alteration of thermoregulatory set point with opioid agonists. J Pharmacol Exp Ther 1990;252:696–705
   Google Scholar
• Andersson S, Lundeberg T. The functional background in acupuncture effects. Scand J Rehabil Med 1993;Suppl 29:31–60
   Google Scholar
• Andersson S, Lundeberg T. Acupuncture — from empiricism to science: functional background to acupuncture effects in pain and disease. Med Hypotheses 1995;45:271–81
   PubMed Web of Science ®Google Scholar
• Thomas M, Lundeberg T. Importance of modes of acupuncture in the treatment of chronic nociceptive low back pain. Acta Anaesth Scand 1994;38:63–9
   PubMed Web of Science ®Google Scholar
• Carlsson C, Sjölund B. Acupuncture and sub-types of chronic pain: assessment of long-term results. Clin J Pain 1994;10:290–5
   PubMed Web of Science ®Google Scholar
• Lement-Jones V, McLloughlin L, Tomlin S, Besser G, Rees L, Wen H. Increased beta-endorphin but not met-enkephalin levels in human cerebrospinal fluid after acupuncture for recurrent pain. Lancet 1980;2:946–9
   Google Scholar
• Zhang A, Xiaoping P, Shaofen X, Jieshi C, Wanying M. Endorphins and acupuncture an-algesia. Chin Med J 1980;93:673–80
   Google Scholar
• Cumming D, Wheeler G. Opioids in exercise physiology. In Speroff L, Lobo R, eds. Role of Opioid Peptides in Reproductive Endocrinol-ogy. Seminars in Reproductive Endocrinology, Vol 5, No 2. New York: Thieme Medical Publishers, 1987:171–9
   Google Scholar
• Hammar M, Berg G, Lindgren R. Does physical exercise influence the frequency of postmeno-pausal hot flushes? Acta Obstet Gynecol Scand 1990;69:409–12
   PubMed Web of Science ®Google Scholar
• Ivarsion T, Spetz AC, Hammar M. Physical exercise and vasomotor symptoms in postmeno-pausal women. Maturitas 1998;29:139–46
   Google Scholar
• Wiklund I, Holst J, Karlberg J, Mattsson L-A, Samsioe G, Uvebrandt M, von Schoultz B. A new methodological approach to the evaluation of quality of life in postmenopausal women. Maturitas 1992;14:211–24
   Google Scholar
• Ost LG. Applied relaxation: description of a coping technique and review of controlled studies. Behav Res Ther 1987;25:397–409
   PubMed Web of Science ®Google Scholar
• Sandkuehler J, Chen J, Cheng G, Randic M. Low frequency stimulation of afferent AS?fibers induces long-term depression of primary afferent synapses with substantia gelatinosa neurons in the rat. J Neurosci 1997;17:6483–91
   PubMed Web of Science ®Google Scholar
• De Quattro V, Lee D, Shkhvatsabaya I, et al. Primary hypertension: left ventricular mass and function, sympathetic nervous system activity and therapy. Health Psychol 1988;7:165–73
   PubMedGoogle Scholar
• Tepper R, Neri A, Kaufman H, Schoenfeld A, Ovadia J. Menopausal hot flushes and plasma fl-endorphins. Obstet Gynecol 1987;70:150–2
   Google Scholar
• Shoupe D, Lobo R. Endogenous opioids in the menopause. In Speroff L, Lobo R, eds. Role of Opioid Peptides in Reproductive Endocrinol-ogy. Seminars in Reproductive Endocrinology, Vol 5, No2. New York: Thieme Medical Publishers, 1987:199–206
   Google Scholar
• Spencer RL, Hruby VJ, Burks TF. Alteration of thermoregulatory set point with opioid agonists. J Pharmacol Exp Ther 1990;252:696–705
   Google Scholar
• Freedman R, Krell W. Reduced thermoregula-tory null zone in postmenopausal women with hot flushes. Am J Obstet Gynecol 1999;181:66–70
   PubMed Web of Science ®Google Scholar
• Uvnds-Mobarg K, Bruzelius G, Alster P, Lunde-berg T. The antinociceptive effect of non-noxious sensory stimulation is mediated partly through oxytocinergic mechanisms. Acta Physiol Scand 1993;149:199–204
   Google Scholar
• Uvnds-Mobärg K. Physiological and endocrine effects of social contact. Ann NY Acad Sci 1997;907:146–63
   Google Scholar
• Levine JD, Gordon NC, Fields HL. The mechan-ism of placebo analgesia. Lancet 1978;2:654–7
   PubMed Web of Science ®Google Scholar
• Ter Riet G, de Craen A, de Boer A, Kessels A. Is placebo analgesia mediated by endogenous opioids? A systemic review. Pain 1998;76:273–5
   PubMed Web of Science ®Google Scholar
• MacLennan A, Lester S, Moore V. Oral oestro-gen replacement therapies versus placebo for hot flushes (Cochrane Review). In The Cochrane Library, Issue 2,2001. Oxford Update Software
   Google Scholar
• Cohen FJ, Lu Y. Characterization of hot flushes reported by healthy postmenopausal women receiving raloxifene or placebo during osteo-porosis prevention trials. Maturitas 1999;34:65–73
   Web of Science ®Google Scholar
• Sloan J, Loprinzi C, Novotny P, Barton D, Lavasseur B, Windschitl H. Methodological lessons learned from hot flash studies. J Clin Oncol 2001;23:4280–90
   Google Scholar
• Freedman RR. Laboratory and ambulatory monitoring of menopausal hot flashes. Psycho-physiology 1989;26:573–9
   PubMed Web of Science ®Google Scholar
• McKinlay S, Brambilla D, Posner J. The normal menopause transition. Maturitas 1992;14:103–15
   PubMed Web of Science ®Google Scholar